Monitoring the performance of the GMK SpheriKA knee prosthesis
Official title: Medacta GMK® SpheriKA and Kinematic Alignment Technique Multicenter, Post-Market Outcome Study
Run by Medacta International SA · NCT05459948 · Data updated 2026-11-12
This study is testing how well the GMK SpheriKA knee prosthesis works for people getting a total knee replacement and how it helps them recover after surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 281 (estimated) |
| Sponsor | Medacta International SA Industry-sponsored |
| Locations | 4 sites (Mérignac and 3 other locations) |
| Status | Recruiting |
| Started | July 30, 2022 |
| Main results expected | May 2035 |
| Study ends | May 2035 |
| Registry record updated | September 29, 2025 |
| Trial ID | NCT05459948 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 18 to 80 who require a primary total knee replacement and have intact collateral ligaments.
✕Probably not a fit
Patients with inflammatory arthritis, morbid obesity, or previous knee surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect clinical and radiological data to evaluate the performance of the GMK SpheriKA knee prosthesis, which is implanted using a kinematic alignment technique. Participants will be monitored postoperatively to assess their recovery and the effectiveness of the prosthesis. The study will involve patients who are undergoing primary total knee replacement and will require their compliance with follow-up evaluations and weight-bearing restrictions.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term performance and safety of the GMK SpheriKA knee prosthesis, potentially improving outcomes for knee replacement patients.
How similar studies have gone: Other studies on knee prosthesis performance have shown success, indicating that post-marketing surveillance can provide critical data for improving surgical outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients willing to sign the informed consent. * Patients able to comply with follow-up requirements, including postoperative weight-bearing restrictions and self-evaluations. * Patients 18 - 80 years of age at the time of surgery. * Patients requiring a primary total knee replacement (on label use). * Patients with intact collateral ligaments. Exclusion Criteria: * Patients with inflammatory arthritis. * Morbidly obese patients, with a body mass index (BMI) \> 40. * Patients with a history of total or unicompartmental reconstruction of the affected joint. * Patients that have had a high tibial osteotomy or femoral osteotomy. * Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device. * Patients with a systemic or metabolic disorder leading to progressive bone deterioration. * Patients that are immunologically compromised or receiving chronic steroids (\> 30 days). * Patients whose bone stock is compromised due to disease or infection, unable to provide adequate support and/or fixation to the prosthesis. * Patients with an active or suspected latent infection in or surrounding the knee joint. * Pregnant or breastfeeding women.
Where it's running
-
Centre de l'Arthrose
Mérignac, France Recruiting -
Clinique de l'Union
Saint-Jean, France Recruiting -
Humanitas Castelli
Bergamo, Italy Recruiting -
Gelenkzentrum Winterthur
Winterthur, Switzerland Recruiting
Study contacts
- Study coordinator: Arianna Girardi
- Email: girardi@medacta.ch
- Phone: +41 91 696 60 60
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Restor3D Outcomes Registry: Patient-specific Joint Implants
This registry tests how patients with FDA-cleared restor3d patient-specific implants fare over up to 5 years, by collecting their own reports on pain, function and quality of life after joint replacement surgeries.
-
Vibration or cool-spray to reduce pain from steroid injections in the hand and wrist
This trial tests whether vibration or vapocoolant spray makes corticosteroid injections in the hands, wrists, or elbows less painful for adults with arthritis, tendinopathy, or nerve compression.
-
Camptodactyly–Arthropathy–Coxa Vara–Pericarditis (CACP) syndrome patient registry and genetic review
This registry collects clinical and genetic information to better understand CACP syndrome in children with confirmed PRG4 mutations.
-
Baduanjin Exercises After Total Knee Replacement
This trial will test whether doing Baduanjin exercises after total knee replacement can reduce pain and improve comfort and recovery in adult patients.
-
Antigravity treadmill rehabilitation after hip or knee replacement
This project will test whether antigravity or body-weight-supported treadmill training helps people aged 60–75 recover walking, balance, and confidence after hip or knee replacement.
-
Smart knee implants and patient satisfaction after knee replacement
This study will see if smart knee implants that send recovery data can help people recover, stay satisfied, and reduce clinic visits after knee replacement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.